Common Stock, Shares, Outstanding of Unicycive Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Unicycive Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Unicycive Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 20,850,363, a 79% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Unicycive Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 20,850,363 -77,008,043 -79% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 14,111,852 -29,461,360 -68% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 119,749,743 +82,143,113 +218% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 11,384,236 -23,371,813 -67% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 97,858,406 +63,104,005 +182% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 43,573,212 +28,337,196 +186% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 37,606,630 +22,372,794 +147% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 34,756,049 +19,524,394 +128% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 34,754,401 +19,666,458 +130% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 15,236,016 +191,518 +1.3% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 15,233,836 +213,319 +1.4% 31 Mar 2023 10-Q 16 May 2023 2023 Q1
Q4 2022 15,231,655 +235,121 +1.6% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 15,087,943 +115,391 +0.77% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 15,044,498 +6,273,208 +72% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 15,020,517 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 14,996,534 +6,482,464 +76% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 14,972,552 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 8,771,290 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q4 2020 8,514,070 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.